NASDAQ NMS - GLOBAL MARKET · CLPT
-2.82% · -$0.3100 · Vol 490.2K
Market closed · last close 4:00 PM ET · price as of 16:09:00 ET
Clearpoint Neuro Inc

Clearpoint Neuro Inc

Health Care
$10.70
Card
Relationship Map

Follow $CLPT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CLPT by email

Veridion Score

BETALOW CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
CLPT
Clearpoint Neuro Inc
Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

35/ 100
Veridion Score
Lower range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CLPT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CLPT catalysts
About Clearpoint Neuro Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2012
Employees
172
Country
US

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$10.85
Day high
$10.98
Day low
$10.58
Previous close
$11.01
52W high
$29.60
-63.85% from high
52W low
$8.66
10% of range
Market cap
$335.9M
EPS
$-1.1200
Beta
0.13
Shares out
30.5M
Volume
490.2K
0.70× rel vol
Avg volume
695.8K
VWAP
$10.73
Price history computed in-house
1W
-6.55%
1M
-23.84%
3M
-38.86%
1Y
-63.85%
YTD
-21.78%
SMA 50 $14.19 · below
SMA 200 $13.37 · below
52W position 10%

CLPT overview

Veridion Score
35
Registered · 2026-10-07
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CLPT.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CLPT Form 4 filings
Public disclosures

Congress activity in CLPT

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

CLPT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CLPT in this window.
Lobbying spend

CLPT lobbying filings, year to date.

Registered lobbying filings matched to Clearpoint Neuro Inc.

$240.0K
Refresh interval: 12hSource: LDA disclosure filings
Trade (domestic/foreign)
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Jul 20, 2026
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Apr 20, 2026
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Jan 20, 2026
Loading news for CLPT
Analyst ratings
Sovereign unlock shows live analyst consensus for CLPT.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.